PLGLB2 抗体 (AA 31-80)
Quick Overview for PLGLB2 抗体 (AA 31-80) (ABIN6753630)
抗原
See all PLGLB2 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 31-80
- 
                                            特异性
- Human PLGLB2 / PLGLB1
- 
                                            纯化方法
- Immunoaffinity purified
- 
                                            免疫原
- 
                        Synthetic peptide located between aa31-80 of human PLGLB2 (Q02325, NP_002656). Percent identity by BLAST analysis: Human (100%).
 Type of Immunogen: Synthetic peptide
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Lyophilized
- 
                                            溶解方式
- Distilled water
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- Lyophilized from PBS, 2 % sucrose.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- 
                        Short term: 4°C
 Long term: -20°C.
 
- 
                                            
- 
    - PLGLB2 (Plasminogen-Like B2 (PLGLB2))
- 
                                            别名
- PLGLB2 / PLGLB1
- 
                                            背景
- 
                        Name/Gene ID: PLGLB2
 Synonyms: PLGLB2, PLGL, PRGB, Plasminogen pseudogene 1, Plasminogen-related protein B, Plasminogen-like B2, PLGP1, Type B plasminogen related
- 
                                            基因ID
- 5342
- 
                                            NCBI登录号
- NP_002656
 抗原
- 
                    
 
                                     
                                     
                                    